Barclays PLC
NYSE:BCSBanks - Diversified
+$0.12 today
- Market cap
- $72.23B
- Beta
- 0.90
- P/E (TTM)
- 9.5
- EPS (TTM)
- $0.53
- Dividend yield
- 1.72%
Volume 4.84M
Average 6.73M
BCS Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Barclays PLCNYSE: BCS
Capital Expenditures · Q2 FY2026 · quarter ended Jun 2026
Capital expenditures outflow grows to £0
Q2 FY2026 capital expenditures was £0, compared with £0 a year earlier. Trailing-twelve-month capital expenditures was £0. Over 3 fiscal years it compounded at +2.1% a year.
Context
- Capital expenditures amounted to 3.7% of revenue in FY2025, up 0.9 pp from a year earlier.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly capital expenditures holds near £0 or moves back toward the trailing-twelve-month quarterly average of £0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
GBP · from the cash flow
- Latest · FY2025
- (1.86B) GBP
- Year-over-year change
- -18.1%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.86B) | -18.1% |
| FY2024 | 2024-12-31 | (1.57B) | +8.4% |
| FY2023 | 2023-12-31 | (1.72B) | +1.6% |
| FY2022 | 2022-12-31 | (1.75B) | -1.5% |
| FY2021 | 2021-12-31 | (1.72B) | — |
Capital Expenditures vs competitors
How BCS compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Capital expenditures amounts to 0.0% of revenue for BCS, versus a peer median of 1.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $6.21B USD | -4.7% | +5.0% | 3.6% | |
| LTM Mar 2026 | €3.33B EUR | -57.6% | -10.9% | 4.7% | |
| LTM Jul 2026 | CA$2.52B CAD | +13.6% | +13.8% | 2.2% | |
| LTM Jul 2026 | CA$2.35B CAD | -0.7% | -3.6% | 1.6% | |
| LTM Jun 2026 | €1.34B EUR | +26.6% | -9.6% | 2.8% | |
| LTM Jun 2026 | £0 GBP | — | +2.1% | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | +1.9% | 0.0% | |
| Peer median (excluding BCS) | — | -0.7% | -0.8% | 1.9% | |
Competitors are the stored peer set for BCS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 8.41B | 7.01B | 6.56B | 8.11B | 7.17B |
| Depreciation & Amortization | 1.67B | 1.72B | 1.78B | 1.7B | 1.76B |
| Deferred Income Tax | (477M) | (513M) | 0 | 0 | 0 |
| Stock-Based Compensation | 477M | 513M | 0 | 0 | 652M |
| Change in Working Capital | 37.04B | 32.42B | (21.9B) | (6.33B) | (2.68B) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 37.04B | 32.42B | (21.9B) | (6.33B) | (2.68B) |
| Other Non-Cash Items | 1.8B | (10.93B) | 12.63B | 3.64B | (13.11B) |
| Operating Cash Flow | 48.92B | 30.23B | (927M) | 7.11B | (6.21B) |
| Capital Expenditures | (1.72B) | (1.75B) | (1.72B) | (1.57B) | (1.86B) |
| Acquisitions (Net) | 1.06B | 0 | (2.42B) | (460M) | 0 |
| Purchases of Investments | (88.17B) | (97.11B) | (86.39B) | (109.93B) | 0 |
| Sales of Investments | 93.1B | 77.1B | 67.09B | 91.32B | 0 |
| Other Investing Activities | 7M | 86M | 23M | 2.75B | 3.45B |
| Investing Cash Flow | 4.27B | (21.67B) | (23.41B) | (17.89B) | 1.6B |
| Debt Repayment | 2.02B | 3.6B | 2.87B | 6.4B | 6.91B |
| Common Stock Issued | 1.12B | 3.21B | 3.25B | 1.68B | 3.78B |
| Common Stock Repurchased | (1.67B) | (4.13B) | (5.25B) | (5.03B) | (6.14B) |
| Dividends Paid | (1.36B) | (1.93B) | (2.26B) | (2.26B) | (2.21B) |
| Other Financing Activities | 0 | (45M) | 0 | 0 | 24.86B |
| Financing Cash Flow | 107M | 696M | (1.39B) | 784M | 27.21B |
| Effect of Forex Changes | (4.23B) | 10.33B | (5.05B) | (2.41B) | (1.74B) |
| Net Change in Cash | 49.06B | 19.58B | (30.78B) | (12.4B) | 20.85B |
| Free Cash Flow | 47.2B | 28.49B | (2.65B) | 5.54B | (8.07B) |
Barclays PLC
NYSE:BCS
Intrinsic Alpha fair value
Locked
Current Price
$21.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.